Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
154 | Gaceta Mexicana de Oncologia | journal | 0.103 Q4 | 7 | 66 | 147 | 1351 | 3 | 129 | 0.03 | 20.47 | 44.62 | |
153 | Journal of the Egyptian National Cancer Institute | journal | 0.124 Q4 | 28 | 19 | 37 | 656 | 12 | 37 | 0.17 | 34.53 | 35.85 | |
152 | Frontiers in Oncology | journal | 0.133 Q4 | 136 | 134 | 52 | 9585 | 19 | 47 | 0.37 | 71.53 | 38.43 | |
151 | ecancermedicalscience | journal | 0.154 Q4 | 47 | 42 | 97 | 828 | 28 | 96 | 0.35 | 19.71 | 39.58 | |
150 | Oncology Reviews | journal | 0.160 Q4 | 31 | 23 | 91 | 1795 | 30 | 83 | 0.38 | 78.04 | 38.55 | |
149 | Oncology Letters | journal | 0.161 Q4 | 81 | 595 | 413 | 15235 | 131 | 413 | 0.32 | 25.61 | 32.06 | |
148 | International Journal of Cancer Management | journal | 0.178 Q4 | 26 | 39 | 96 | 1069 | 34 | 95 | 0.44 | 27.41 | 39.06 | |
147 | Experimental and Therapeutic Medicine (discontinued) | journal | 0.184 Q4 | 63 | 384 | 349 | 10869 | 152 | 349 | 0.44 | 28.30 | 32.66 | |
146 | Chinese Journal of Cancer Research (discontinued) | journal | 0.206 Q4 | 41 | 64 | 156 | 1906 | 74 | 155 | 0.51 | 29.78 | 39.46 | |
145 | Journal of Gastric Cancer | journal | 0.219 Q4 | 37 | 39 | 80 | 863 | 55 | 79 | 0.69 | 22.13 | 23.46 | |
144 | Current Cancer Therapy Reviews | journal | 0.226 Q4 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | 35.37 | |
143 | Bulletin du Cancer | journal | 0.230 Q4 | 44 | 172 | 583 | 5179 | 372 | 535 | 0.64 | 30.11 | 42.69 | |
142 | Journal of Breast Cancer | journal | 0.290 Q4 | 48 | 74 | 185 | 1767 | 133 | 179 | 0.89 | 23.88 | 38.42 | |
141 | Journal of B.U.ON. | journal | 0.307 Q4 | 37 | 147 | 433 | 4317 | 353 | 376 | 0.80 | 29.37 | 35.75 | |
140 | Oncology Research and Treatment | journal | 0.348 Q4 | 55 | 170 | 434 | 3086 | 393 | 348 | 0.83 | 18.15 | 28.67 | |
139 | Cancer Informatics | journal | 0.387 Q3 | 37 | 15 | 78 | 514 | 86 | 74 | 1.19 | 34.27 | 22.92 | |
138 | Reports of Practical Oncology and Radiotherapy | journal | 0.396 Q3 | 36 | 64 | 103 | 1588 | 185 | 100 | 2.12 | 24.81 | 43.66 | |
137 | Tumori | journal | 0.413 Q3 | 59 | 168 | 489 | 4447 | 561 | 468 | 1.09 | 26.47 | 44.91 | |
136 | In Vivo | journal | 0.419 | 72 | 152 | 445 | 5307 | 667 | 443 | 1.33 | 34.91 | 35.33 | |
135 | Molecular Medicine Reports | journal | 0.428 Q3 | 86 | 533 | 529 | 15143 | 658 | 529 | 1.41 | 28.41 | 38.86 | |
134 | Cancer Biomarkers | journal | 0.432 Q3 | 54 | 52 | 209 | 2163 | 288 | 190 | 0.88 | 41.60 | 35.92 | |
133 | Journal of Experimental Therapeutics and Oncology | journal | 0.435 Q3 | 40 | 26 | 64 | 1153 | 99 | 61 | 1.15 | 44.35 | 28.74 | |
132 | Cancers | journal | 0.462 Q3 | 133 | 68 | 350 | 5711 | 460 | 348 | 1.32 | 83.99 | 38.83 | |
131 | Clinical and Translational Oncology | journal | 0.529 Q3 | 61 | 141 | 446 | 4892 | 617 | 399 | 1.35 | 34.70 | 40.81 | |
130 | Current Problems in Cancer | journal | 0.571 Q3 | 47 | 25 | 73 | 1356 | 80 | 53 | 1.17 | 54.24 | 20.69 | |
129 | Brain Tumor Pathology | journal | 0.606 Q3 | 45 | 38 | 88 | 938 | 165 | 87 | 1.81 | 24.68 | 18.04 | |
128 | Human Cell | journal | 0.612 Q3 | 44 | 15 | 60 | 428 | 91 | 59 | 1.51 | 28.53 | 30.21 | |
127 | Analytical Cellular Pathology | journal | 0.670 Q3 | 35 | 38 | 52 | 1241 | 98 | 48 | 1.88 | 32.66 | 23.95 | |
126 | International Journal of Biological Markers | journal | 0.676 Q3 | 47 | 56 | 110 | 2155 | 222 | 106 | 1.91 | 38.48 | 44.41 | |
125 | Oncology Research | journal | 0.677 Q3 | 76 | 36 | 147 | 1019 | 303 | 146 | 2.13 | 28.31 | 31.49 | |
124 | Technology in Cancer Research and Treatment | journal | 0.698 Q3 | 72 | 62 | 187 | 2166 | 439 | 177 | 2.47 | 34.94 | 26.42 | |
123 | Medical Oncology | journal | 0.701 Q3 | 90 | 545 | 679 | 15251 | 1299 | 667 | 1.87 | 27.98 | 36.16 | |
122 | Cancer Research and Treatment | journal | 0.706 Q3 | 58 | 42 | 40 | 955 | 102 | 40 | 2.55 | 22.74 | 37.61 | |
121 | Pathology and Oncology Research | journal | 0.743 Q3 | 61 | 143 | 319 | 4994 | 644 | 318 | 1.83 | 34.92 | 40.17 | |
120 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.756 Q3 | 68 | 93 | 267 | 3431 | 591 | 256 | 2.01 | 36.89 | 40.32 | |
119 | Neoplasma | journal | 0.762 Q3 | 57 | 95 | 246 | 2716 | 497 | 246 | 1.93 | 28.59 | 39.04 | |
118 | International Journal of Hyperthermia | journal | 0.776 Q3 | 98 | 84 | 243 | 3930 | 666 | 226 | 2.97 | 46.79 | 29.78 | |
117 | Journal of Oral Pathology and Medicine | journal | 0.782 Q3 | 95 | 117 | 364 | 4105 | 961 | 354 | 2.46 | 35.09 | 42.05 | |
116 | Cancer Genomics and Proteomics | journal | 0.785 Q3 | 50 | 36 | 98 | 1930 | 231 | 98 | 2.05 | 53.61 | 36.63 | |
115 | Anticancer Research | journal | 0.788 Q3 | 136 | 733 | 2116 | 24307 | 4706 | 2109 | 2.04 | 33.16 | 30.24 | |
114 | Breast Cancer: Basic and Clinical Research | journal | 0.795 Q3 | 35 | 16 | 46 | 694 | 111 | 44 | 2.40 | 43.38 | 44.44 | |
113 | Current Hematologic Malignancy Reports | journal | 0.796 Q3 | 44 | 41 | 97 | 2338 | 217 | 96 | 2.31 | 57.02 | 34.62 | |
112 | European Journal of Cancer Prevention | journal | 0.799 Q3 | 88 | 84 | 229 | 3604 | 732 | 224 | 3.17 | 42.90 | 39.68 | |
111 | Infectious Agents and Cancer | journal | 0.836 Q3 | 47 | 34 | 93 | 1620 | 242 | 93 | 2.30 | 47.65 | 48.94 | |
110 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.839 Q3 | 65 | 75 | 350 | 2424 | 636 | 334 | 1.81 | 32.32 | 39.87 | |
109 | Leukemia Research | journal | 0.885 Q3 | 96 | 361 | 1486 | 9435 | 2501 | 989 | 1.93 | 26.14 | 43.68 | |
108 | Japanese Journal of Clinical Oncology | journal | 0.924 Q3 | 95 | 207 | 627 | 4602 | 1453 | 567 | 2.06 | 22.23 | 15.77 | |
107 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.935 Q3 | 90 | 105 | 351 | 3181 | 814 | 334 | 2.47 | 30.30 | 33.69 | |
106 | Anti-Cancer Drugs | journal | 0.936 Q3 | 102 | 136 | 391 | 5235 | 1230 | 383 | 2.81 | 38.49 | 42.08 | |
105 | Cancer Cell International | journal | 0.938 Q3 | 80 | 53 | 118 | 2058 | 342 | 117 | 2.57 | 38.83 | 41.24 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®